Following engagement with the extracellular tumor environment, MMP-2/9 cleavage at the intervening PLGC(Me)AG linker within ACPP “activates” the ACPP by removing the spatial inhibition of the polyanionic moiety (Figure 1C). The gene discussed is ACP3; the disease is neoplasm.